Your browser doesn't support javascript.
loading
A novel prostate cancer subtyping classifier based on luminal and basal phenotypes.
Weiner, Adam B; Liu, Yang; Hakansson, Alex; Zhao, Xin; Proudfoot, James A; Ho, Julian; Zhang, Jj H; Li, Eric V; Karnes, R Jeffrey; Den, Robert B; Kishan, Amar U; Reiter, Robert E; Hamid, Anis A; Ross, Ashely E; Tran, Phuoc T; Davicioni, Elai; Spratt, Daniel E; Attard, Gerhardt; Lotan, Tamara L; Lee Kiang Chua, Melvin; Sweeney, Christopher J; Schaeffer, Edward M.
Affiliation
  • Weiner AB; Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.
  • Liu Y; Veracyte Inc, San Diego, California, USA.
  • Hakansson A; Veracyte Inc, San Diego, California, USA.
  • Zhao X; Veracyte Inc, San Diego, California, USA.
  • Proudfoot JA; Veracyte Inc, San Diego, California, USA.
  • Ho J; Veracyte Inc, San Diego, California, USA.
  • Zhang JH; Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.
  • Li EV; Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Karnes RJ; Department of Urology, Mayo Clinic, Rochester, Minnesota, USA.
  • Den RB; Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Kishan AU; Department of Radiation Oncology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.
  • Reiter RE; Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.
  • Hamid AA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Ross AE; Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Tran PT; Department of Radiation Oncology, University of Maryland, Baltimore, Maryland, USA.
  • Davicioni E; Veracyte Inc, San Diego, California, USA.
  • Spratt DE; Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, USA.
  • Attard G; Cancer Institute, University College London, London, UK.
  • Lotan TL; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Lee Kiang Chua M; Division of Radiation Oncology, National Cancer Centre, Singapore, Singapore.
  • Sweeney CJ; Division of Medical Sciences, National Cancer Centre, Singapore, Singapore.
  • Schaeffer EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Cancer ; 129(14): 2169-2178, 2023 07 15.
Article in En | MEDLINE | ID: mdl-37060201
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Limits: Humans / Male Language: En Journal: Cancer Year: 2023 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Limits: Humans / Male Language: En Journal: Cancer Year: 2023 Document type: Article Affiliation country: United States Country of publication: United States